Free Trial

Silverback Therapeutics (SBTX) SEC Filings & 10K Form

Silverback Therapeutics logo
$14.88 0.00 (0.00%)
As of 04/17/2025

Recent Silverback Therapeutics SEC Filings

DateFilerForm TypeView
04/08/2025
3:45 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Shawver Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
1:26 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Shawver Laura (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/24/2025
6:57 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Flynn James E (Filed by)
Form SCHEDULE 13D/A
03/21/2025
5:30 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Karas Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:03 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Karas Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:05 PM
Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/20/2025
6:02 AM
Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2025
6:04 AM
Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2025
4:12 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Shawver Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
4:18 PM
Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
4:19 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Shawver Laura (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
3:35 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Shawver Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
11:06 AM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Shawver Laura (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
4:21 PM
Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form S-3ASR
01/13/2025
7:08 AM
Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
5:24 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Shawver Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:36 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Shawver Laura (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2024
3:20 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
3:20 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
6:52 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Dorsey Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
6:53 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Chakma Justin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
4:24 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2024
4:41 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Chakma Justin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:02 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
5:30 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
5:30 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
4:31 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Dorsey Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
3:48 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
10:15 AM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Lowenthal Richard E (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/09/2024
4:43 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
4:25 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
11:38 AM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Shawver Laura (Reporting)
Form 144/A
12/06/2024
6:15 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Chakma Justin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:30 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/05/2024
4:06 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2024
4:25 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
6:01 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
5:22 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Shawver Laura (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
3:42 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Karas Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
3:11 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Chakma Justin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:30 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
[Action Required] Claim Your FREE IRS Loophole Guide (Ad)

This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.

So claim your FREE copy of this 2025 Gold Guide to learn more.
11/21/2024
3:30 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
2:21 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Chakma Justin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2024
7:16 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt III, L.P. (Reporting)
Deerfield Mgmt IV, L.P. (Reporting)
Deerfield Private Design Fund III, L.P. (Reporting)
Deerfield Private Design Fund IV, L.P. (Reporting)
Flynn James E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
6:02 AM
Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
6:00 AM
Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
3:30 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2024
3:30 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2024
3:30 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Scott Kathleen D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
3:01 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Scott Kathleen D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
10:28 AM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Tanimoto Sarina (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
6:02 AM
Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
3:27 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2024
3:28 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
3:15 PM
Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:26 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:29 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:30 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Karas Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:06 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Karas Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:24 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:25 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
9:31 AM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Lowenthal Richard E (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
3:30 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
5:41 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
5:38 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
ORBIMED CAPITAL LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:43 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
ORBIMED CAPITAL LLC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2024
5:47 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:48 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:49 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Scott Kathleen D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:51 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Karas Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
5:51 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Dorsey Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:18 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Scott Kathleen D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2024
3:30 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:30 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:30 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Dorsey Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
6:59 AM
Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
3:30 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
3:30 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
11:07 AM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Tanimoto Sarina (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/11/2024
4:03 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
4:04 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
2:15 PM
Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
5:46 AM
Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2024
4:06 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Dadoo Rajeev (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
4:13 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:00 PM
Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
7:47 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Pratik Shah Living Trust dated June 15, 2011 (Filed by)
Form SC 13D/A
06/17/2024
5:39 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Shah Pratik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:30 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:18 PM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Pratik Shah Living Trust dated June 15, 2011 (Filed by)
Form SC 13D/A
06/11/2024
10:36 AM
Silverback Therapeutics (Subject)
ARS Pharmaceuticals, Inc. (Subject)
Lowenthal Richard E (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Real Americans Don’t Wait on Wall Street’s Next Move (Ad)

What's happening in the markets right now should concern every freedom-loving American who's worked hard and saved smart. Your 401(k) doesn't deserve to be dragged through the mud by tariffs, trade wars, reckless spending, and political standoffs. And you don't have to stand by while Wall Street plays roulette with your future.

The Golden Path to Retirement gives you the whole story.
06/07/2024
8:09 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Pratik Shah Living Trust dated June 15, 2011 (Reporting)
Shah Pratik (Reporting)
Form 4/A
06/07/2024
8:11 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Shah Pratik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:32 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Pratik Shah Living Trust dated June 15, 2011 (Reporting)
Shah Pratik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
6:51 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
6:52 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
6:01 AM
Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
5:57 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Lowenthal Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
5:59 PM
Silverback Therapeutics (Issuer)
ARS Pharmaceuticals, Inc. (Issuer)
Tanimoto Sarina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:08 PM
Silverback Therapeutics (Filer)
ARS Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SBTX) was last updated on 4/21/2025 by MarketBeat.com Staff
From Our Partners